NCT02692976View on ClinicalTrials.gov

Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

March 6, 2019

Conditions
Prostatic NeoplasmsImmunotherapyDendritic CellsVaccines
Interventions
BIOLOGICAL

mDC vaccination

Intranodal mDC vaccination

BIOLOGICAL

pDC vaccination

Intranodal pDC vaccination

BIOLOGICAL

mDC and pDC vaccination

Intranodal mDC/pDC vaccination

Trial Locations (1)

6500 HB

Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT02692976 - Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients | Biotech Hunter | Biotech Hunter